Jul 17, 2019
Sobi Publishes Report for Second Quarter 2019
Jul 09, 2019
Switching to Extended Half-life Prophylaxis Impacted Clinical Outcomes and Improved Quality of Life for People With Haemophilia A or B
Jul 08, 2019
People With Haemophilia and Female Carriers in Sweden Have Higher Risk of Anxiety, Depression and Pain, Based on Treatment Patterns: Swedish Orphan Biovitrum
Jun 25, 2019
Sobi Presents Study Data Supporting Increased Possibilities and Improved Clinical Outcomes for People With Haemophilia at ISTH
Jun 18, 2019
New Data Demonstrates Impact of Emapalumab in Patients With Macrophage Activation Syndrome (MAS)
Jun 12, 2019
Sobi Acquires Emapalumab and Related Assets
Jun 12, 2019
Sobi Strengthens Focus and Increases Investments in Late-Stage Development in Haematology and Immunology
May 14, 2019
Rare Strength Powers Growth - Sobi Capital Markets Day 2019
Apr 30, 2019
Sobi(TM) Appoints Amy Pott as New Head of Sobi North America
Apr 25, 2019
Sobi Publishes Report for First Quarter 2019
Apr 18, 2019
Sobi(TM) Publishes 2018 Annual and Sustainability Report
Mar 25, 2019
Sobi and Novimmune Selected as Honourees for 2019 National Organization for Rare Disorders (NORD) Rare Impact Award in Industry Innovation for Gamifant® (emapalumab)
Feb 21, 2019
Invitation to Sobi Capital Markets Day 14 May 2019
Feb 07, 2019
Sobi Presents Comprehensive Study Data on Extended Half-life Haemophilia Treatments at EAHAD
Jan 24, 2019
Sobi(TM) Completes Acquisition of Synagis® US Rights From AstraZeneca and Exercises Authorisation to Issue Shares
Dec 03, 2018
Data Presented at ASH Support Emapalumab as an Innovative, Targeted Therapeutic Option for Primary HLH
Nov 22, 2018
Late-breaking Abstract at ASH Supports Evidence on Transformative First-ever Treatment in Primary HLH
Nov 19, 2018
Sobi(TM) Appoints Paula Treutiger as Head of Communications and Investor Relations
Nov 13, 2018
Sobi(TM) to Acquire Synagis® US Rights From AstraZeneca - Creates a Platform for Global Growth
Oct 31, 2018
Sobi(TM) Publishes the Report for the Third Quarter 2018